News

Pfizer has entered into a strategic funding agreement with Blackstone Life Sciences to support the development of its experimental obesity treatment, berobenatide. Under the…
Read More...

Biomatter, a Lithuania-based biotechnology company, has raised $18 million in an oversubscribed Series A funding round to expand its artificial intelligence (AI)-powered enzyme design…
Read More...

Bristol Myers Squibb (BMS) has announced plans to bring its research and development operations together under a single organisation to accelerate drug discovery and strengthen its…
Read More...

Neurosterix has raised $105 million in Series B financing to advance its experimental treatments for schizophrenia and other neuropsychiatric disorders. The funding will primarily…
Read More...

Promega Corporation has signed a licensing agreement with BrainXell to bring its NanoLuc, NanoBiT and HaloTag technologies into human stem cell-based models used for neurological…
Read More...

Takeda has launched ORZEYFUL (oveporexton) in the United States for adults living with narcolepsy type 1 (NT1), making the first-in-class orexin receptor treatment available by…
Read More...

Charles River Laboratories has announced new investments across its global Microbial Solutions business to increase manufacturing capacity, improve customer support and strengthen…
Read More...

ChronicleBio and Prolong Pharmaceuticals have announced a partnership to evaluate PP-007 as a potential treatment for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The…
Read More...

Eli Lilly has reported positive one-year results from a Phase 3b clinical trial evaluating the combination of Taltz (ixekizumab) and Zepbound (tirzepatide) in adults living with active…
Read More...

Oyster Therapeutics, formerly known as Kesmalea Therapeutics, has raised $60 million in Series A financing to advance its next-generation targeted protein degradation programmes for…
Read More...

ProBio has entered into an exclusive global licensing agreement with South Korean biotechnology company AbTis to develop a new antibody-drug conjugate (ADC) for cancer treatment. The…
Read More...

Moderna has reported a 29% increase in revenue for the third quarter of 2026, supported by stronger international sales of its COVID-19 vaccine and progress in its cancer vaccine…
Read More...

AstraZeneca has acquired Omniose, a US-based preclinical biotechnology company developing vaccines against serious bacterial infections. The acquisition will strengthen AstraZeneca's…
Read More...

Shanton Pharma has received regulatory waivers from the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA), removing the need for additional pediatric…
Read More...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Johnson & Johnson's (J&J) Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for adults with…
Read More...

Biotechnology company Network Bio has announced a research collaboration with Duke University to develop artificial intelligence (AI) models that could improve disease detection,…
Read More...

Alfasigma has received European Commission approval to expand the use of filgotinib for adults with active axial spondyloarthritis (axSpA), a chronic inflammatory disease that mainly…
Read More...

Boehringer Ingelheim has entered into a major oncology partnership with China's Sino Biopharmaceutical Limited (SBP Group) to develop next-generation cancer treatments using…
Read More...

Evommune, Inc. has entered into an exclusive licensing agreement with China's Hinova Pharmaceuticals to develop and commercialise EVO570, an experimental oral drug designed to treat…
Read More...

T-Therapeutics, a biotechnology company based in Cambridge, UK, has raised $133 million in an oversubscribed Series B financing round to advance its experimental treatments for cancer…
Read More...